Dr. Wolf is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
704 S Webster Ave
Green Bay, WI 54301Phone+1 920-338-6868Fax+1 920-338-6869
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Obstetrics and Gynecology, 1986 - 1990
Northeast Ohio Medical UniversityClass of 1986
University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology
Certifications & Licensure
AZ State Medical License 2011 - 2026
GA State Medical License 2014 - 2026
NY State Medical License 2020 - 2026
TN State Medical License 2022 - 2026
VA State Medical License 2022 - 2026
IN State Medical License 2014 - 2025
MT State Medical License 2023 - 2025- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
- Join now to see all
Clinical Trials
- Gene Therapy in Treating Patients With Ovarian Cancer Start of enrollment: 1998 Sep 01
- PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2002 Jul 01
- Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2004 Sep 02
- Join now to see all
Publications & Presentations
PubMed
- 25 citationsPredisposing risk factors for palmar-plantar erythrodysesthesia when using liposomal doxorubicin to treat recurrent ovarian cancer.Janos L. Tanyi, Judith A. Smith, Lafit Ramos, Crystal L. Parker, Mark F. Munsell
Gynecologic Oncology. 2009-08-01 - 82 citationsAdenocarcinoma in situ of the cervix: Significance of cone biopsy marginsJudith K. Wolf, Charles F Levenback, Anais Malpica, Mitchell Morris, Thomas W. Burke
Obstetrics and Gynecology. 1996-07-01 - 160 citationsBRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomasKwong Kwok Wong, Yvonne T.M. Tsang, Michael T. Deavers, Samuel C. Mok, Zhifei Zu
The American Journal of Pathology. 2010-10-01
Press Mentions
Provista Diagnostics Appoints Judith K. Wolf, M.D., as Chief Medical OfficerJuly 28th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
